Terconazole
Triazole Derivatives
- Drug class
- Triazole Derivatives
- Availability
- Prescription only
- Routes
- Vaginal
- Markets covered
- 2
- Products on record
- 2
- FDA reports (12 mo)
- 29
Overview
Plain-language summary, compiled from the cited regulatory records
Terconazole is an antifungal medication belonging to the triazole derivative class [1]. It is approved for the local treatment of vulvovaginal candidiasis, commonly known as yeast infections [1]. To ensure terconazole is the appropriate treatment, the diagnosis of vulvovaginal candidiasis should be confirmed through methods such as KOH smears and/or cultures, as terconazole is effective only for infections caused by the genus Candida [1].
Terconazole is available under various brand names [N]. In the past 12 months, there have been 29 adverse event reports associated with terconazole [2]. The most frequently reported issues in these reports include product dose omission, malaise, nausea, product container issues, and product leakage [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 28, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
4% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). 4% is effective only for vulvovaginitis caused by the genus Candida , the diagnosis should be confirmed by KOH smears and/or cultures.
How to take
CACanada· Health Canada
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 10e84353-93d2-46… · revised January 28, 2026 [PDF]
- [2]Health Canada (DPD) · 02247651 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.